Ride Along with UNBRIDLED ACCESS
Boehringer Ingelheim International GmbH

Ride Along with UNBRIDLED ACCESS

No. of episodes
2
Latest episode
2026-10-07

Where can you listen?

It’s time for the candid conversations equine medicine deserves.

Join Dr. Joe Lyman, equine veterinarian and Director of Professional Services at Boehringer Ingelheim, as he sits down with leading voices to explore the questions that challenge veterinarians to keep learning, sharpen their expertise, and deliver the best possible care.

From emerging diseases and groundbreaking research to practice challenges and life behind the scenes, each episode explores the ideas, experiences, and innovations shaping the future of equine care.

Hear the stories behind the science and the people behind the profession—with practical perspectives to help you stay informed, connected, and ready for what’s next.

UNBRIDLED ACCESS from Boehringer Ingelheim is a professional community supporting equine veterinarians through expert insights, peer connections, shared learning, and exclusive experiences.

UNBRIDLED ACCESS is a trademark of Boehringer Ingelheim Vetmedica GmbH, used under license. ©2026 Boehringer Ingelheim Animal Health USA Inc., Johns Creek, GA. All rights reserved.
US-EQU-0236-2026

Episodes

Questions & Answers

How many episodes are there of Ride Along with UNBRIDLED ACCESS?

There are 2 episodes avaiable of Ride Along with UNBRIDLED ACCESS.

What is Ride Along with UNBRIDLED ACCESS about?

We have categorized Ride Along with UNBRIDLED ACCESS as:

  • Business
  • Health & Fitness
  • Medicine

Where can you listen to Ride Along with UNBRIDLED ACCESS?

Ride Along with UNBRIDLED ACCESS is available, among others places, on:

  • Spotify
  • Apple Podcasts
  • Podtail
  • Google Podcasts

When did Ride Along with UNBRIDLED ACCESS start?

The first episode of Ride Along with UNBRIDLED ACCESS that we have available was released 16 September 2026.

Who creates the podcast Ride Along with UNBRIDLED ACCESS?

Ride Along with UNBRIDLED ACCESS is produced and created by Boehringer Ingelheim International GmbH.